D.A. Davidson Maintains Accolade(ACCD.US) With Hold Rating
BofA Securities Maintains Accolade(ACCD.US) With Buy Rating, Announces Target Price $7
Leerink Partners Maintains Accolade(ACCD.US) With Buy Rating, Maintains Target Price $9.5
Stifel Maintains Buy on Accolade, Lowers Price Target to $8
Accolade Analyst Ratings
Truist Adjusts Price Target on Accolade to $9 From $14, Maintains Buy Rating
Needham Reiterates Buy on Accolade, Maintains $13 Price Target
Accolade Analyst Ratings
Guggenheim: Maintaining the Accolade (ACCD.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $17.00 to $13.00.
Guggenheim Maintains Buy on Accolade, Lowers Price Target to $13
Accolade Analyst Ratings
Wells Fargo: Maintaining the Accolade (ACCD.US) rating, adjusted from a wait-and-see shareholding rating to a shareholding wait-and-see rating, and the target price was adjusted from $12.00 to $10.00.
Accolade Analyst Ratings
Wells Fargo Maintains Equal-Weight on Accolade, Lowers Price Target to $10
Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating
Barclays: Maintaining the Accolade (ACCD.US) rating, adjusted from a wait-and-see shareholding rating to a shareholding wait-and-see rating, and the target price was adjusted from $13.00 to $11.00.
Accolade Analyst Ratings
Barclays Remains a Hold on Accolade (ACCD)
Accolade Analyst Ratings
Leerink Partners Initiates Coverage On Accolade With Outperform Rating, Announces Price Target of $16